Crosstalk within GPCR Heteromers in Schizophrenia and Parkinson's Disease: Physical or Just Functional?

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|8|1119-1134

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.8, 2012-03, pp. : 1119-1134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor Heteromers in Parkinson’s Disease and L-DOPA-Induced Dyskinesia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1101-1113

Bentham Science Publishers

Access to resources Recommend Favorite

GPCR Heteromers and their Allosteric Receptor-Receptor Interactions

By  

Current Medicinal Chemistry, Vol. 19, Iss. 3, 2012-01 ,pp. : 356-363

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Selectivity in GPCR Heterocomplexes

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-01 ,pp. : 851-855

Bentham Science Publishers

Access to resources Recommend Favorite

Physical and Mental Fatigue in Parkinson's Disease: Epidemiology, Pathophysiology and Treatment

By Lou Jau-Shin  

Drugs & Aging, Vol. 26, Iss. 3, 2009-01 ,pp. : 195-208

Adis International

Access to resources Recommend Favorite

L-DOPA and Serotonergic Neurons: Functional Implication and Therapeutic Perspectives in Parkinson's Disease

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 4, 2011-12 ,pp. : 305-320

Bentham Science Publishers

Access to resources Recommend Favorite